CXCL12 and acute myeloid leukemia: The crosstalk between leukemic stem/progenitor cells and bone marrow microenvironment has been highlighted as an important process for the resistance to chemotherapy and disease relapse in AML, mainly through the activation of the CXCL12/CXCR4 pathway (Bernasconi and Borsani, 2019).